Suppr超能文献

通过向正常大鼠注射肝脏生长因子诱导肝脏生长。

Hepatic growth induced by injection of the liver growth factor into normal rats.

作者信息

Díaz Gil J J, Rúa C, Machin C, Cereceda R M, García-Cañero R, de Foronda M, Pérez de Diego J, Trilla C, Escartin P

机构信息

Department of Experimental Biochemistry, Clínica Puerta de Hierro, Madrid, Spain.

出版信息

Growth Regul. 1994 Sep;4(3):113-22.

PMID:7858484
Abstract

Normal Wistar rats injected with the liver growth factor (LGF), a mitogen specific for liver cells, experienced hepatic growth. LGF shows two peaks of activity in vivo, both of them mitogenic. Rats injected either with 6.8 ng or 3.9 micrograms LGF/rat every 3-4 days experienced liver growth showing a see-saw profile. Dry liver weight usually peaked at day 2 (microgram doses) or at day 3 (ng doses) after each injection, with increases of about 30% over controls. Liver DNA synthesis, measured by [3H]-thymidine incorporation, peaked 24 h after LGF injection at both doses. Liver protein synthesis, measured by [14]C-leucine incorporation, usually peaked 24 h after DNA synthesis maximums. Mitogen-stimulated cells were also assessed by immunohistochemical staining for proliferating cell nuclear antigen in livers of LGF-injected rats. Rats injected with rat serum albumin purified from normal rats to serve as controls showed a 6% increase in dry liver weight, but when serum albumin from 3-day fasted rats was injected instead, the increase was not statistically significant. The mild effect of rat serum albumin could be due to the lipid content of the solutions injected, but the level of lipids/mg protein in LGF solutions was half that determined with serum albumin from 3-day fasted rats. From the microscopic and ultramicroscopic studies carried out in rat livers injected with LGF at each dose, we observed: (1) an increase in the number of hepatocytes undergoing mitosis; (2) transient increases in lipid and glycogen contents, as occur after liver resection; (3) no signs of degeneration, such as the appearance of amyloids or fibrosis; (4) no increase in lysosome number, as in hepatotoxicity; (5) no alterations in endothelial or Kupffer cells; and (6) no ultrastructural signs of degeneration either in cytoplasmic organelles (rough endoplasmic reticulum, mitochondria) or in nuclei. One year after LGF injection, rat liver, pancreas, kidneys and spleen were normal, with no signs of degeneration or onset of fibrosis.

摘要

给正常的Wistar大鼠注射肝细胞生长因子(LGF)(一种对肝细胞具有特异性的促有丝分裂原)后,肝脏出现生长。LGF在体内呈现两个活性峰值,均具有促有丝分裂作用。每3 - 4天给大鼠注射6.8 ng或3.9 μg LGF/只,大鼠肝脏生长呈现出一种跷跷板模式。每次注射后,干肝重通常在第2天(微克剂量组)或第3天(纳克剂量组)达到峰值,比对照组增加约30%。通过[3H] - 胸腺嘧啶核苷掺入法测定的肝脏DNA合成,在两种剂量的LGF注射后24小时达到峰值。通过[14C] - 亮氨酸掺入法测定的肝脏蛋白质合成,通常在DNA合成达到最大值后24小时达到峰值。还通过免疫组织化学染色检测LGF注射大鼠肝脏中增殖细胞核抗原,对有丝分裂原刺激的细胞进行评估。注射从正常大鼠纯化的大鼠血清白蛋白作为对照的大鼠,其干肝重增加了6%,但当注射来自禁食3天大鼠的血清白蛋白时,增加量无统计学意义。大鼠血清白蛋白的轻微作用可能归因于所注射溶液的脂质含量,但LGF溶液中脂质/毫克蛋白质的水平是禁食3天大鼠血清白蛋白中脂质水平的一半。从对各剂量LGF注射大鼠肝脏进行的显微镜和超显微镜研究中,我们观察到:(1)进行有丝分裂的肝细胞数量增加;(2)脂质和糖原含量短暂增加,如同肝切除术后那样;(3)没有退化迹象,如淀粉样物质或纤维化的出现;(4)溶酶体数量没有增加,不像肝毒性时那样;(5)内皮细胞或库普弗细胞没有改变;(6)细胞质细胞器(粗面内质网、线粒体)或细胞核也没有超微结构退化迹象。LGF注射一年后,大鼠的肝脏、胰腺、肾脏和脾脏均正常,没有退化或纤维化开始的迹象。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验